Sign up to save your podcasts
Or
Share The lure of the NASDAQ for Biotechs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The lure of the NASDAQ for Biotechs
In this special Flashcast episode of the WTR Healthcare Happenings podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.
View all episodes
By Joe BrunettoIn this special Flashcast episode of the WTR Healthcare Happenings podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.